Objective: Mitochondrial production of oxidants contributes to a variety of pathological conditions including the vascular complications of diabetes, neurodegenerative diseases, and cellular senescence. We postulated that a transcriptional coactivator, peroxisome proliferator activated receptor-g coactivator 1a (PGC-1a), a major regulator of oxidative metabolism and mitochondrial biogenesis, could be involved in the transcriptional regulation of the mitochondrial antioxidant defense system in vascular endothelial cells.
Introduction
Excessive production of reactive oxygen species (ROS) in the mitochondria plays a major role in the development of several diseases including the vascular and neurological complications of diabetes [29, 46] , neurodegenerative diseases like Parkinson's disease [13] , Alzheimer [1] and epilepsy [9] , ageing [11] and cancer [31, 32] . In diabetic patients, hyperglycemia causes increased ROS production [29] that eventually leads to endothelial dysfunction.
Endothelial dysfunction is a sensitive indicator of cardiovascular disease, predicts its prognosis and is closely associated with the development of atherosclerosis [7] .
The Peroxisome Proliferator Activated Receptor (PPAR) g Coactivator 1-a (PGC-1a) [42] is a transcriptional coactivator identified as an upstream regulator of lipid catabolism, mitochondrial number and function. Consistent with its emerging role as a central regulator of energy metabolism, PGC-1a is abundantly expressed in tissues with high metabolic rates.
Increased mitochondrial activity and electron flow through the ETC (electron transport chain) may be responsible for an increased production of superoxide (O 2 S À ) [20] , that when dismutated generates the highly toxic hydrogen peroxide (H 2 O 2 ), unless adequate detoxifi- cation mechanisms are activated. We postulated the existence of a mechanism for the coordinated regulation of mitochondrial oxidative metabolism and ROS protection systems should exist. As PGC-1a is known to regulate mitochondrial activity, we decided to test whether PGC-1a could play such a role. This idea was supported by recent observations that indicated increased levels of Manganese Superoxide Dismutase (MnSOD) mRNA in C2C12 myotubes that overexpressed PGC-1a [39] . As a model system we chose primary endothelial cells, where excessive production of O 2 S À and H 2 O 2 in the mitochondria has been shown to mediate high-glucose dependent oxidative stress [29] .
Until recently, the only well-known antioxidant mitochondrial protein was MnSOD [25] . A complete mitochondrial detoxification system has now been described. It is composed of Peroxiredoxin III [44] , Peroxiredoxin V [18] , mitochondrial Thioredoxin [37] , mitochondrial Thioredoxin Reductase [8, 22, 26, 41] , and mitochondrial splicing variants of Glutaredoxin [24] and Glutathione Reductase [16] . The mitochondrial Uncoupling Protein 2 (UCP-2) forms a proton channel that has been proposed to prevent superoxide production [5, 21] .
We found that PGC-1a expression in primary endothelial cells results in the up-regulation of mitochondrial number and activity and of a full set of oxidative stress protective genes. This regulatory activity helps to prevent increased ROS accumulation, endothelial dysfunction and apoptosis in high glucose conditions.
Methods

Cell culture
Human Umbilical Vein Endothelial Cells (HUVEC) were isolated from umbilical cord veins and cultured as previously described [28] . Umbilical cords were obtained from Ruber International Hospital (Madrid, Spain) with the approval of the donors and the ethics committee of the institution. Bovine Aortic Endothelial Cells (BAEC) from bovine aortas were isolated and cultured as previously described [23] . Aortas were obtained from an authorized slaughterhouse. Mouse Aortic Endothelial Cells (MAEC) were isolated and cultured as previously described [14] from C57B mice provided by our animal facility. The protocols used conform to the Declaration of Helsinki and to the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institute of Health (NIH Publication No. 85-23).
Adenoviral vectors and infection
Three copies of the HA tag were inserted at the Nterminus of PGC-1a, and subcloned in pShuttle-CMV (Quantum). Adenoviruses were generated and purified according to the manufacturer's instructions. Confluent HUVEC or BAEC cells were exposed to adenoviral vectors at an moi of 50 for 12 h.
RNA purification and analysis
Total RNA was isolated with Trizol. The expression levels were determined by reverse transcription (RT) of total RNA followed by PCR analysis (RT-PCR). One microgram of total RNA was reverse transcribed by extension of random primers. The PCR program used was as follows: 2 min at 94 8C; 30-40 cycles of 30W at 92 8C, 30W at 55 8C and 30W at 72 8C; and a final extension step of 5V at 72 8C. A PCR reaction was also performed on total RNA that had not been reverse transcribed to control for the absence of genomic DNA amplification. PCR products were resolved on 1% agarose gels. Relative expression levels were determined by Real-Time PCR (rPCR) in a 7000 Sequence Detection System (Applied Biosystem). Thermal conditions were: 2V at 50 8C, 10V at 95 8C; and 45 cycles of 15W at 95 8C, 30W at 55-60 8C, 30W at 72 8C.
Western blot
Whole-cell extracts (WCE) were prepared as previously described [27] . Protein samples were resolved on SDS-PAGE, transferred onto Immobilonk-P membrane (Millipore), and analyzed by Western blotting with chemiluminescence detection (ECL, Amersham).
siRNA
The siRNAs were synthesized using the Silencer siRNA Construction Kit from Ambion, from the following DNA oligos:
GAPDH siRNA: Sense control DNA and Antisense Control DNA (provided with the kit) PGC-1a siRNA: 585/s 5V-aacgctttattgctccatgaacctgtctc-3V, 585/as 5V-aattcatggagcaataaagcgcctgtctc-3. 
Mitochondrial transmembrane potential (DWm)
Changes in DW m were determined as differences in the tetramethylrhodamine methyl ester (TMRM) versus MitoTracker Green signal ratio. Fluorochromes were added to the cell culture medium at 50 nM. Cells were incubated for 30 min at 37 8C, trypsinized and resuspended in PBS. Fluorescence intensity was measured by flow cytometry.
Reactive oxygen species
Cells were incubated with 2 AM 5-chloromethyl-2V 7V-dichlorodihydrofluorescein diacetate acetyl ester (CM-H 2 DCFDA) for 30 min (added directly to the media). The cells were then trypsinized and resuspended in PBS. Fluorescence intensity was measured by flow cytometry.
Chromatin immunoprecipitation (ChIP)
The experimental conditions used have been described previously [35] . PGC-1a was immunoprecipitated with a polyclonal a-PGC-1a antibody. The immunoprecipitated DNA was analyzed by rPCR.
Statistics
Data are expressed as meansFS.D. values. Statistical evaluation of the data was performed by analysis of variance (ANOVA) or non-parametric tests as appropriate. Values were considered to be statistically significant at Pb0.05. nz3 in all the experiments.
Materials
DMNQ (2,3-dimetoxi-1-naphthoquinone) was from Calbiochem. Trizol reagent is from Invitrogen. 488 annexin V conjugate, CM-H 2 DCFDA, TMRM and MitoTracker Green were from Molecular Probes. The fluorescent substrates for Caspase-3 (Ac-DEVD-AMC) and Caspase-9 (Ac-LEHD-AFC) were from PharMingen and Biochem. Substrates of Caspases (CaspGLOW staining kit) were from Alexis Biochemicals, HOECHST42 was from Sigma.
The following antibodies were used: Mouse monoclonal a-cytochrome c (Clone 7H8.2C12) was purchased from BD PharMingen; mouse monoclonal a-Peroxiredoxin-V (Clone 44) was from BD Biosciences; mouse monoclonal a-GAPDH was from Chemicon and rabbit polyclonal aCaspase-3 (H-277), a-PGC-1 (H-300) and a-UCP-2 (C-20) antibodies were from Santa Cruz Biotechnology. Rabbit polyclonal a-MnSOD (SOD-110) was from Stressgen; rabbit polyclonal a-catalase was from Chemicon Int.; and rabbit polyclonal a-Peroxiredoxin III, a-Thioredoxin 2 and a-Thioredoxin Reductase 2 were form LabFrontiers. Horseradish peroxidase-conjugated secondary antibodies were from Santa Cruz Biotechnology (a-goat) and Amersham (a-rabbit and a-mouse).
Results
PGC-1a is present in vascular endothelial cells
PGC-1a is a highly regulated protein and its levels vary greatly among tissues and in changing metabolic situations [33] . It was therefore important to determine if PGC-1a was present in the vascular endothelium. We tested HUVEC and BAEC for the presence of PGC-1a mRNA by RT-PCR. As shown in Fig. 1A , a band corresponding to the PGC-1a fragment was detected in cDNA samples but not in RNA controls. The identity of the band was confirmed by DNA sequencing.
We also tested the presence of PGC-1a protein in HUVEC and BAEC, WCE by Western blot. As a positive control we used cells infected with a recombinant adenovirus expressing PGC-1a. We could reproducibly identify PGC-1a in both HUVEC and BAEC cells (Fig. 1A) .
We then decided to investigate whether PGC-1a activity in the endothelium would result in the induction of oxidative metabolism genes, as has been described in other cell systems [45] . We constructed a recombinant adenovirus expressing HA-tagged PGC-1-a (Ad-PGC-1) to ensure the ubiquitous expression of PGC-1a in endothelial cells. HUVEC were infected with increasing doses (moi 1-100) of Ad-PGC-1 or the control empty virus (Ad), and induction of the ETC genes, Cytochrome C (Cyt C), Cytochrome Oxidase subunits II and IV (COX II , COX IV ) and ATP Synthetase h subunit (ATPaseg), was tested 72 h postinfection by RT-PCR. We observed a dose-dependent induction of the mRNA expression levels for all the ETC genes tested (Fig. 1B) .
To determine if the induction of ETC gene expression did result in an increased mitochondrial mass, we labeled A clear shift to higher fluorescence values can be observed in Ad-PGC-1 cells.
PGC-1a induces oxidative stress protective genes
In order to evaluate PGC-1a activity under mitochondrial oxidative stress, we analyzed whether PGC-1a was active and able to regulate ETC and lipid metabolism genes in 30 mM glucose [12] . HUVEC infected with Ad, Ad-PGC-1 or non-infected control, were cultured in low (5 mM) and high (30 mM) glucose for 48 h. The results, obtained by rRT-PCR analysis ( Fig. 2A) showed that PGC-1a is able to induce ETC (Cyt C, ATPaseh, and COX IV ) and lipid catabolism genes, Medium-Chain Acyl-CoA Dehydrogenase (MCAD), Carnitine Palmitoyltransferase I (CPT-I), Long-Chain Acyl Co-A Oxidase (ACO) in oxidative stress conditions (Table 1) .
We then analyzed the effect of PGC-1a expression on the mRNA levels of the mitochondrial ROS detoxification machinery: MnSOD, Peroxirredoxins 3 and 5 (Prx3, Prx5) mitochondrial Thioredoxin (TRX2), and mitochondrial Thioredoxin Reductase (TRXR2), UCP-2, and catalase. UCP-2 has been shown to be regulated at the transcriptional level by PGC-1a [45] . Catalase is an enzyme that degrades H 2 O 2 and is mainly localized in peroxisomes. We observed that PGC-1a was able to induce the expression of all these genes in both normal (5 mM glucose) and oxidative stress (30 mM glucose) conditions. Importantly, the mRNA levels of a cytoplasmic detoxification enzyme, Cu/Zn Superoxide Dismutase (Cu/ ZnSOD) were not modulated by PGC-1a, suggesting that the effect of PGC-1a is specific for the mitochondrial system (Fig. 2B) . We have extended our observations to other endothelial cell systems: BAEC (Fig. 2C) and MAEC (our unpublished results).
PGC-1 associates with the promoters of MnSOD, UCP-2 and Prx5 genes
In order to evaluate whether PGC-1a induction of oxidative stress protective genes was the result of the direct interaction of PGC-1a with their regulatory promoter regions, we carried out ChIP experiments. HUVEC, were cultured in low or high glucose for 48 h. Following chromatin preparation, the DNA fragments were immunoprecipitated and analyzed by rPCR. As shown in Fig. 3 , MnSOD, UCP-2 and Prx5 promoter fragments were specifically enriched in the IP (a-PGC-1) fraction of Ad-PGC-1. Importantly, UCP-2 had already been proposed to be a direct transcriptional target of PGC-1a [45] . We conclude that the effects of PGC-1a are likely to be mediated by its direct association with the promoter regions of these genes ( Table 2) .
PGC-1a increases cellular levels of mitochondrial antioxidant proteins
We then assessed whether cells overexpressing PGC-1a modified the cellular content of antioxidant proteins. The results shown in Fig. 4A indicate that PGC-1a expression increases the levels of MnSOD, Catalase, Prx5, Prx3, UCP-2, TRXR2, and TRX2, in both normal glucose and oxidative stress conditions (30 mM glucose) ( Table 1) . Similar results were obtained in different endothelial cells systems like BAEC (Fig. 4B) and MAEC (our unpublished results). Table 1 Primer pairs used in rRT-PCR to quantify changes in gene expression
Target
Forward Reverse hACO 5V-ccgagagatcgagaacatgatc-3V 5V-ccaagcctcgaaggtgagttc-3V hATPaseh 5V-gttccatcctgtcagggactatg-3V 5V-tgtgctctcacccaaatgctgg-3V hCOX IV 5V-acgagctcatgaaagtgttgtg-3V 5V-aatgcgatacaactcgactttctc-3V hMCAD 5V-gatttagttttgagttcaccgaac-3V 5V-tccaagacctccacacagttctc-3V hMnSOD 5V-aggttagatttagccttattccac-3V 5V-ttactttttgcaagccatgtatctttc-3V hPrx 3 5V-cctttggatttcacctttgtgtg-3V 5V-caaaccaccattctttcttggtg-3V hPrx5 5V-ccaatcaaggtgggagatgcc-3V 5V-gcaggtgtgtcttggaacatc-3V hTRX2 5V-gtccacaccactgtgcgtgg-3V 5V-ttgcagggagatggctcagcg-3V hCat 5V-gacaatcagggtggtgctcc-3V 5V-gaatcgcattcttaggcttctc-3V hCPT1 5V-actgtgaacaggtatctacagtc-3V 5V-tacagcagatccatggcataatag-3V hPGC-1 5V-ggcagtagatcctcttcaagatc-3V 5V-tcacacggcgctcttcaattg-3V hCytc 5V-cttcggagcgggagtgttcg-3V 5V-cagatgatgcctttgttcttattg-3V hFNA 5V-cagaaatgactattgaaggcttgc-3V 5V-ccacggatgagctgtcaggag-3V hUCP-2 5V-tacaaagccggattccggcagc-3V 5V-ctccttggatctgtaaccggac-3V hCOX II 5V-cattattcctagaaccaggcgac-3V 5V-gaattaattctaggacgatgggc-3V hCu/ZnSOD 5V-cggaggctttgaaggtgtgg-3V 5V-ctccaacatgcctctcttcatcc-3V bUCP-2 5V-cggctacagatccaaggagaa-3 5V-ccgatgccagcatgctcaga-3V bMnSOD 5V-ggaacaacaggtcttatccccct-3V 5V-ttacttgctgcaagccgtgtatc-3V bTRX2 5V-cagggagatggctcagcga-3V 5V-gaccacaccattgtgcatgga-3V hmCytC 5V-gccaataagaacaaaggcatca-3V 5V-gttttgtaataaataaggcagtgg-3V bGAPDH 5V-agtggggtgatgctggtgctg-3V 5V-cgcctgcttcaccaccttctt-3V 18S rRNA Pre-developed TaqMan 
Expression of PGC-1a reduces the accumulation of ROS
To establish whether the observed induction of oxidative stress proteins would increase the cellular detoxification capacity, we incubated HUVEC, with 20 AM DMNQ, a quinone that blocks ETC Complex II [10] , and induces a dose-dependent production of superoxide [6] . The level of cellular ROS was estimated by CM-H 2 DCFDA labeling. We observed that PGC-1a expression reduced the amount of ROS accumulated in DMNQ treated cells by about 50% (Fig. 5A ). Since DMNQ is expected to induce the same ROS production in the absence or presence of PGC-1a, we concluded that PGC-1a expression does increase the cell detoxification capacity.
We then investigated whether PGC-1a would reduce the levels of ROS present in cells treated with high glucose. HUVEC accumulate about 30% more ROS in 30 mM than in 5 mM glucose. PGC-1a expression reduced ROS levels by 50% in both low and high glucose conditions (Fig. 5B) . Importantly, Ad-PGC-1 cells in 30 mM glucose have about 25% less ROS than control cells in 5 mM glucose, suggesting that PGC-1a can prevent high glucose dependent oxidative stress. A similar result was obtained in BAEC cells (Fig. 5C ).
PGC-1 can prevent mitochondrial dysfunction
High glucose treatment of HUVEC and other cell types causes a drop in mitochondrial potential that can be attributed to the inhibition of the ETC by ROS [34] , and precedes the activation of the apoptotic cascade. The reduced accumulation of ROS, in PGC-1a expressing cells, might help to prevent mitochondrial dysfunction. Therefore, we determined DW m in HUVEC, cultivated in low or high glucose for 48 h. MitoTracker Green labeling was used to estimate mitochondrial mass. Changes in DW m were calculated as differences in the TMRM/ MitoTracker Green fluorescence ratio. High glucose treatment reduced mitochondrial potential in control HUVEC by 30%. Mitochondrial DW m was about 50% higher in cells expressing PGC-1a. High glucose treatment reduced DW m in Ad-PGC-1 cells by only 15%, and therefore was still about 25% higher than in controls in low glucose, supporting the notion that PGC-1a can prevent mitochondrial dysfunction in stress conditions (Fig. 6A) . 
The primer set hp1.3MnSOD is located aproximately 1.3 kb upstream of the SOD2 transcription start site. The primer set hp3MnSOD is located aproximately 3.4 kb upstream of the SOD2 transcription start site. The primer set hpPrx5 is located aproximately 1 kb upstream of the prxV transcription start site. The primer set hpUCP2 is located right upstream of the ucp-2 transcription start site. The primer set hghactin is located within the bactin CDS.
PGC-1a expression prevents apoptotic cell death
To investigate whether PGC-1a activity, was relevant to cell survival, we monitored apoptotic cell death of HUVEC under oxidative stress. It has been reported that exposure to ROS, such as H 2 O 2 , or stress inducers that are not themselves ROS, like high glucose, induces apoptosis in HUVEC and other endothelial cell types [3, 30, 48, 12] . HUVEC were exposed to 250 Amol/L H 2 O 2 , and cell death was monitored by flow cytometry. After 12 h of treatment 90-100% of control cells had undergone apoptosis, but 50% PGC-1a expressing cells were still alive (PI À , annexin V À ) (Fig. 6B) . We concluded that the higher detoxification capacity of PGC-1a expressing cells could prevent apoptotic cell death in oxidative stress conditions. We next studied whether PGC-1a could prevent apoptotic death induced by high glucose in HUVEC. We observed that in low glucose about 10% of the control cells died every 24 h. PGC-1a expressing cells had a slightly lower proportion of apoptotic cells (9%) than controls. In high glucose 20% of the control cells died every 24 h. Only about 12% of PGC-1a-expressing cells died per day in 30 mM glucose (Fig. 6B) , supporting the notion that PGC-1a expression protects cells from oxidative stress-induced apoptosis. [30, 48] and other oxidative stress agents like high glucose [36, 43] proceeds through the activation of the mitochondrial apoptotic cascade, which involves the sequential activation of caspase-9 and caspase-3. The protective effect of PGC-1a on apoptosis prompted us to investigate whether PGC-1a activity prevents the activation of the mitochondrial apoptosis cascade. HUVEC were exposed to 250 AM H 2 O 2 , and activation of caspase-9 and caspase-3 was monitored at different times in WCE incubated with fluorescent caspase substrates (Fig. 7A) . To directly monitor the activation of the caspases within living cells, HUVEC were labeled with fluorescent caspase-9 and caspase-3 substrates, and examined by confocal microscopy (Fig. 7B) . Control cells showed the expected sequential activation of caspase-9, that peaked 4.5 h after H 2 O 2 addition, and caspase-3, that peaked 9 h after H 2 O 2 addition. PGC-1a expression both delayed and reduced the activation of caspase-9 and caspase-3. Caspase-9 activity was lost after 6 h, and caspase-3 activity could not be detected after 12 h. We concluded that PGC-1a can protect HUVEC from apoptosis induced by H 2 O 2 , preventing the activation of the mitochondrial apoptotic cascade.
Suppression of endogenous PGC-1a expression results in the down-regulation of the mitochondrial detoxification machinery
To determine whether the PGC-1a protein present in resting primary endothelial cells was required to sustain the basal levels of mitochondrial detoxification enzymes we decided to suppress PGC-1a expression, transfecting PGC1a siRNA or GAPDH siRNA as a negative control in BAEC cells.
As shown in Fig. 8 we were able to suppress PGC-1a expression at the mRNA (Fig. 8A) and protein (Fig. 8B ) levels, and this downregulation resulted in reduced levels of MnSOD, Prx3, Prx5, TRX2 and TRXR2, supporting the notion that endogenous PGC-1a does indeed regulate their expression.
Discussion
Oxidative stress is the leading cause of various pathological conditions that affect systems as diverse as the central nervous system, heart, lung, liver or the vascular wall. However, our understanding of the mechanisms that allow cells to protect themselves from oxidative stress is still very poor. Our results allow us to propose that PGC-1a is a major transcriptional regulator of the mitochondrial detoxification system.
Our results demonstrate that PGC-1a, a positive regulator of oxidative metabolism, co-regulates the induction of a set of proteins that participate in the cellular response to mitochondrial oxidative stress. This positive regulation increases the cellular capacity to detoxify mitochondrial ROS, preventing endothelial dysfunction and apoptotic cell death in response to oxidative stress conditions, such as high glucose.
We interpret these results as evidence that reduced ROS levels allow a better function of mitochondrial ETC. Cells that expressed PGC-1a showed a higher survival rate, supporting the hypothesis that PGC-1a-mediated increase in the cell scavenging activity enable the mitochondria to respond better to metabolic overload. These results have important implications since they point to PGC-1a as a potential target for drug development.
Furthermore, we showed that suppression of PGC-1a expression in BAEC cells by siRNA results in a strong reduction in the levels of the mitochondrial detoxification proteins MnSOD, Prx3, Prx5, TRX2, TRXR2, and UCP-2. These results suggest that the endogenous endothelial PGC1a protein plays a crucial protective role in the endothelium.
To our knowledge this is the first report of a mechanism that coordinately regulates the mitochondrial antioxidant defense system at the transcriptional level. In order to support the notion that PGC-1a could be directly involved in the transcriptional regulation of antioxidant genes, we tested PGC-1a interaction with the promoter regions of MnSOD [2, 17, 19, 38, 40] UCP-2 [15, 47] , and Prx5. Our data showed that PGC-1a could be found associated with the regulatory promoter sequences of MnSOD, UCP-2 and Prx5. Importantly, UCP-2 has already been proposed to be a direct target of PGC-1a transcriptional regulation [45] . We believe that our results indicate that PGC-1a is likely to be directly involved in the transcriptional regulation of the complete set of oxidative stress genes tested here, although alternative indirect mechanisms are also possible.
One interesting observation that came along with the characterization of PGC-1a activity in the endothelium was the effect of high glucose on the expression of oxidative stress protective proteins. We observed that high glucose had a positive effect on the mRNA levels of the detoxification genes, both in the absence and presence of PGC-1a. However, this positive regulation was not paralleled by a corresponding increase in protein levels. We interpret this result as evidence of a dual regulatory mechanism that might render ineffective the initial increase in mRNA levels. Previous studies on the topic do not shed any light on the possible mechanisms involved, although a decrease in the expression levels of protein synthesis genes has been described in streptozotocin-induced diabetic mice [4] . However, future studies will be necessary to elucidate this point.
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